Abstract
specific interactions such as hydrogen bond or covalent bond with residues in zone 2.
23
(1) Trimethoxyphenyl
24
The most remarkable privileged structures as ring A is trimethoxyphenyl. improves the basicity of the system due to its basic character, furthermore, the 6 protonation of nitrogen turns it into a strong hydrogen bond thus it provides additional 7 hydrogen bonding interaction. Another important property of nitrogen-containing 8 heterocycles is polarity which can be used as a mean of reducing the lipophilic 9 character and improving water solubility and oral absorption. These heterocycles have 10 been applied in the construction of CBSIs [20] . Herein, we mainly focus on the 11 substitution of trimethoxyphenyl with these heterocyclic structures which can interact 12 to the zone 2 of colchicine binding pocket.
13
In 2008, Nilantha Sirisoma firstly reported some aminoquinazolines endowed 14 with potent cytotoxic effects, compounds 15 and MPC-6827 (16) showed the most 15 potent cytotoxicity against multiple tumor cell lines with IC 50 values of 2-10 nM [21] . 16 Afterwards, they proposed and validated tubulin as the main target of these 17 compounds [22] . Early clinical trials of MPC-6827 was carried out for patients with 18 advanced cancer [23] , however, this promising candidate has been discontinued by All these cases show that aminoquinazoline fragment is a privileged structure 38 utilized in the design of CBSIs, and N-methyl, 4-methoxy groups are essential for 39 potent activity. However, recent work carried out by Mouad Alami et al. affording 21 40 and 22 showed that N-methyl and aminoquinazoline could be respectively replaced by 27 showed higher anti-tubulin polymerization activity than colchicine, the 14 bioavailability of the hydrochloride salt of 27 was up to 47%, and it significantly 15 inhibited tumor growths in four xenograft models including resistance-tumor bearing 16 mice models without causing significant loss of body weight [38] . All these results
17
indicate that 27 can be developed as a promising new orally active anti-cancer agent, 18 and it is worth mentioning that 26 and 27 possess a structural similarity with the 19 chalcones type compound 85 .
20
(4) Covalent privileged structures. 21 Irreversible inhibitors also represent an important class of CBSIs, they 22 irreversibly bind into the colchicine binding pocket by covalent bonds formed with 23 some specific residues. These binding modes may circumvent drug resistance caused 24 by mutations of tubulin residues and trigger microtubule disruption.
25
Urea moiety is one of the most common structures of covalent CBSIs, and it can 26 be found in the structures of N-Phenyl-N'-(2-chloroethyl)urea (CEU) (28) and its 27 analogues (29-31) ( Figure 6 ). These anti-tubulin agents can acylate Gluβ198 that is a 28 residue located in a pocket adjacent to the colchicine binding site [39, 40] 4-methoylphenyl and indoles, which will be briefly discussed in this section.
15
(1) 4-methoylphenyl 16 This motif derived from natural CBSIs such as CA-4, colchicine (a similar 17 tropolone motif) was often templated in the development of CBSIs. Structurally, the 18 presence of a para-methoxy group is required for the biological activity; steric effect 
(3) Chalcones

27
The length of the bridge can be extended with maintained biological properties, Chalcone with a α,β-unsaturated ketone structure represents a key structural 35 motif in biologically active molecules both from synthetic and natural sources.
36
Research regarding the anti-tubulin activity of chalcones was initiated by Ducki et al., α,β-unsaturated ketone especially a methyl substituted moiety is a privileged structure 7 to replace cis-olefin as the bridge of CBSIs.
8
The spatial relationship between the two aromatic rings of CA-4 and colchicine 9 is an important structural feature that determines its ability to bind to tubulin. The 10 enone structure of chalcones is a semi-rigid backbone with three rotatable bonds. As suggesting that five-membered rings seem to be the best option for this class CBSIs. Fusing cis-olefin into ring B represents another tactic to lock the cis double bond.
5
The works of fusing carbocyclic rings into ring B were mainly described by Pinney's 6 and Alami's groups. Pinney's group was the first to attempt this modification leading 7 to the discovery of 92 (Figure 12) Recently, Xingshu Li's group described the fusing of carbocyclic rings into indole Lysβ352 and Lysβ254 [136] . All these cases showed that anthracenone is a privileged 13 structure in the skeletons of non-classical CBSIs.
14
Prodrugs of CBSIs
15
CBSIs either from natural sources or synthetic origins usually suffer from poor Other than phenolic hydroxyl group, the NH in indole ring of CBSIs is also a good 34 modifiable position to produce phosphate prodrug. For example, water solubility of 35 compound 72-P was increased to 125 mg/mL in sodium phosphate buffer, and the t 1/2 36 of 72-P (157.5 min) was greatly improved in comparison with CA-4 (t 1/2 < 60 min ),
37
which may lead to a higher bioavailability in vivo [79] . facilitates medicinal chemists to discover more structurally novel CBSIs. 
Privileged structures in CBSIs
 Privileged structures in CBSIs are discussed based on classical CBSIs and non-classical CBSIs, respectively.  Classical CBSIs are typically characterized with an "aromatic ring -bridge -aromatic ring" which have a globular or butterfly like shape, and privileged structures of these three fragments are highlighted.  Non-classical CBSIs are usually characterized with more planar or rigid skeletons, and they are structurally different from the common structures of colchicine and CA-4 analogues.
Prodrugs of CBSIs
 Some prodrug forms frequently used to improve aqueous solubility and PK profiles are highlighted.  The most classical form is the phosphate prodrug due to its good chemical stability and 
